117 related articles for article (PubMed ID: 21823034)
1. NT-proBNP as a biomarker for the assessment of a potential cardiovascular drug-induced liability in beagle dogs.
Crivellente F; Tontodonati M; Fasdelli N; Casartelli A; Dorigatti R; Faustinelli I; Cristofori P
Cell Biol Toxicol; 2011 Dec; 27(6):425-38. PubMed ID: 21823034
[TBL] [Abstract][Full Text] [Related]
2. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
[TBL] [Abstract][Full Text] [Related]
3. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
4. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
5. A novel and integrated approach for the identification and characterization of drug-induced cardiac toxicity in the dog.
Casartelli A; Lanzoni A; Comelli R; Crivellente F; Defazio R; Dorigatti R; Fasdelli N; Faustinelli I; Pagliarusco S; Tontodonati M; Cristofori P
Toxicol Pathol; 2011 Feb; 39(2):361-71. PubMed ID: 21422262
[TBL] [Abstract][Full Text] [Related]
6. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
[TBL] [Abstract][Full Text] [Related]
7. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
8. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.
Schmidt MK; Reynolds CA; Estrada AH; Prosek R; Maisenbacher HW; Sleeper MM; Oyama MA
J Vet Cardiol; 2009 May; 11 Suppl 1():S81-6. PubMed ID: 19394913
[TBL] [Abstract][Full Text] [Related]
9. NT-proBNP: a marker of preclinical cardiac damage in arterial hypertension.
Di Stasio E; Russo A; Mettimano M; Viviani D; Scagliusi A; Bruno A; Giuliani A; Isgrò MA; Romitelli F; Savi L
Clin Chim Acta; 2011 May; 412(11-12):1106-11. PubMed ID: 21376713
[TBL] [Abstract][Full Text] [Related]
10. The use of NT-proBNP assay in the management of canine patients with heart disease.
Oyama MA; Singletary GE
Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):545-58. PubMed ID: 20610010
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.
Ettinger SJ; Farace G; Forney SD; Frye M; Beardow A
J Am Vet Med Assoc; 2012 Jan; 240(2):171-80. PubMed ID: 22217025
[TBL] [Abstract][Full Text] [Related]
12. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J
Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
[TBL] [Abstract][Full Text] [Related]
13. Cardiac troponin T and NT-proBNP as biomarkers of early myocardial damage in amitriptyline-induced cardiovascular toxicity in rats.
Sorodoc V; Sorodoc L; Ungureanu D; Sava A; Jaba IM
Int J Toxicol; 2013; 32(5):351-7. PubMed ID: 24055824
[TBL] [Abstract][Full Text] [Related]
14. Weekly variability of plasma and serum NT-proBNP measurements in normal dogs.
Kellihan HB; Oyama MA; Reynolds CA; Stepien RL
J Vet Cardiol; 2009 May; 11 Suppl 1():S93-7. PubMed ID: 19395335
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma N-terminal ProBNP levels in unmedicated patients with major depressive disorder.
Politi P; Minoretti P; Piaggi N; Brondino N; Emanuele E
Neurosci Lett; 2007 May; 417(3):322-5. PubMed ID: 17350167
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease.
Boswood A; Dukes-McEwan J; Loureiro J; James RA; Martin M; Stafford-Johnson M; Smith P; Little C; Attree S
J Small Anim Pract; 2008 Jan; 49(1):26-32. PubMed ID: 18005104
[TBL] [Abstract][Full Text] [Related]
17. NT-proBNP is not elevated in patients with obstructive sleep apnoea.
Hübner RH; El Mokhtari NE; Freitag S; Rausche T; Göder R; Tiroke A; Lins M; Simon R; Bewig B
Respir Med; 2008 Jan; 102(1):134-42. PubMed ID: 17892929
[TBL] [Abstract][Full Text] [Related]
18. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R
Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
[TBL] [Abstract][Full Text] [Related]
19. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
Chrysochou C; Manzoor S; Wright J; Roberts SA; Wood G; McDowell G; Kalra PA
Kidney Blood Press Res; 2009; 32(5):373-9. PubMed ID: 19887825
[TBL] [Abstract][Full Text] [Related]
20. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
